# A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

> **NCT01621204** · PHASE3 · COMPLETED · sponsor: **McMaster University** · enrollment: 74 (actual)

## Conditions studied

- Immune Thrombocytopenic Purpura

## Interventions

- **DRUG:** Eltrombopag
- **DRUG:** IVIG infusion

## Key facts

- **NCT ID:** NCT01621204
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621204, "A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01621204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*